Closed 21% Discount vs CMP

Vineet Laboratories Limited Rights Issue 2026

BSE, NSE
Issue Price ₹30 Per equity share
Current Market Price ₹37.99 21% Discount
Rights Ratio (RE) 13:12 13 share for every 12 held
Total Issue Size ₹29.96 Cr Capital being raised
Record Date 23 Dec 2025 Eligibility cut-off date
INTERACTIVE ESTIMATOR

Vineet Laboratories Limited Rights Entitlement & Capital Calculator

Calculate your eligible rights share allocation and total application cost based on the official 13:12 ratio at ₹30.00 per share.

Ratio: 13:12
Shares
Quick select:
Enter your holdings as on 23 Dec to recalculate.
Entitlement Calculation Terms
Rights Price ₹30.00
Entitlement Ratio 13:12
Current CMP ₹37.99
Record Date 23 Dec
For every 12 shares in your demat, you are entitled to apply for 13 rights shares.
ALLOTMENT ESTIMATE 13:12 Entitlement
Eligible Rights Shares -- Based on 13:12 ratio
Total Investment Required -- @ ₹30.00/share
Potential Savings vs CMP --
Theoretical Valuation (Post-Dilution) Ex-Rights Model
Expected Ex-Date (TERP) ₹33.84
RE Fair Value ₹3.84
*TERP is the estimated theoretical stock price after dilution at ₹30.00. RE Fair Value = (TERP - Issue Price).
Apply online via Net Banking ASBA. Amount remains blocked in your bank account until allotment.
MARKET QUOTE & TECHNICAL TREND

Vineet Laboratories Limited Stock Quote & Price Trend

BSE: VINEET
₹37.99 ▼ ₹0.29 (0.76%)
CMP vs Issue Price: 21% Discount (Issue Price: ₹30.00)
Period High ₹41.73 Highest in range
Period Low ₹36.96 Lowest in range
Rights Issue Price ₹30.00 Per equity share
TERP (Ex-Price) ₹33.84 Estimated post-rights
Price Advantage 21% Discount vs Current Market Price
STRUCTURE & SPECIFICATIONS

Issue Overview & Specifications

Company Name Vineet Laboratories Limited
Rights Entitlement (Ratio)
13:12 (13 share for every 12 held)
Issue Price ₹30 per equity share
Face Value N/A
Total Issue Size ₹29.96 Crores
Number of Shares Offered TBA
Listing Exchanges BSE, NSE
SCHEDULE & DATES

Vineet Laboratories Limited Rights Issue Timetable

1
Record Date 23 Dec 2025

Cut-off date determining eligible shareholders entitled to receive Rights Entitlements (RE).

2
Issue Opens Date 01 Jan 2026

Bidding opens. Eligible investors can apply online via Net Banking ASBA.

3
Last Date for On-Market Renunciation 27 Jan 2026

Last trading day to sell or transfer your Rights Entitlements (RE) on the stock exchange.

4
Issue Closes Date 30 Jan 2026

Final deadline to submit your ASBA rights issue application with blocked funds.

5
Basis of Allotment TBA

Finalization of allotment by the registrar and company.

6
Listing & Credit of Shares TBA

Allotted rights shares are credited to demat accounts and commence trading on BSE/NSE.

STEP-BY-STEP PROCESS

How to Apply for Vineet Laboratories Limited Rights Issue

1
Check Rights Entitlement (RE) in Demat

Once the record date passes, Rights Entitlements (RE) will be credited directly to your demat account under temporary ISIN COMPANY-RE.

2
Decide: Apply, Renounce (Sell), or Apply for Additional Shares

You can apply for your exact entitlement, apply for additional shares over and above your entitlement, or sell your RE shares in the stock market before the renunciation deadline.

3
Apply via Net Banking ASBA

Log in to your bank's net banking portal (HDFC, ICICI, SBI, Axis, Kotak, etc.). Go to IPO / Rights Issue section, select Vineet Laboratories Limited Rights Issue, enter your Demat account (BOID/DPID) details, and submit.

QUESTIONS & ANSWERS

Vineet Laboratories Limited Rights Issue FAQs

Vineet Laboratories Limited Rights Issue offers equity shares at ₹30.00 per share with an entitlement ratio of 13:12.
The official record date for Vineet Laboratories Limited Rights Issue is 23 Dec 2025. Shareholders holding shares in demat on this date are entitled to Rights Entitlements (RE).
Rights Entitlements (RE) are credited directly to eligible shareholders' demat accounts under temporary ISIN COMPANY-RE. You can either apply for shares using REs or renounce (sell) them in the stock market during the trading window.
Investors can apply online via Net Banking through ASBA (Applications Supported by Blocked Amount) by selecting Vineet Laboratories Limited Rights Issue in the IPO/Rights section and entering Demat account (BOID/DPID) details.
If you do not apply or sell your Rights Entitlements on the stock exchange before the last date of renunciation, the REs will expire and lapse worthless, resulting in shareholding dilution.
தொடர்புடைய தலைப்புகள்